Merck's Q2 Revenue Beats Expectations on Strong Keytruda and Treatment Sales

  • 3 months ago
Merck reported second-quarter revenue surpassing Wall Street expectations, driven by strong sales of its cancer drug Keytruda and other treatments. Adjusted earnings per share also exceeded expectations. The company raised its full-year sales forecast slightly but lowered its profit guidance due to acquisition charges. Keytruda sales rose 16%, while sales for its HPV vaccine were nearly flat. The newly launched Winrevair and Capvaxive showed promising starts.
Transcript
00:00It's Benzinga, and here's what's on the block.
00:02Merck reported second quarter revenue surpassing Wall Street expectations, driven by strong
00:07sales of its cancer drug Keytruda and other treatments.
00:10Adjusted earnings per share also exceeded expectations.
00:14The company raised its full year sales forecast slightly, but lowered its profit guidance
00:18due to acquisition charges.
00:20Keytruda sales rose 16% while sales for its HPV vaccine were nearly flat.
00:25The newly launched WinRiver and Capvaxiv showed promising starts.
00:28For all things money, visit Benzinga.com.

Recommended

0:35
I
Up next
Morgan Stanley Beats Q3 Estimates, Profits Surge More Than 30%
Benzinga
0:41
Venture Capital Funding For Generative AI Startups Account For 40% Of All Cloud Funding
Benzinga
0:39
ASML Shares Drop 16% After Releasing Weak Sales Forecast
Benzinga
0:43
GM Partners With Lithium Americas In $625 Million Joint Venture To Develop Nevada Lithium Mine
Benzinga
0:46
Harris Proposes Medicare Funding for At-Home Care As Costs Outpace Inflation, Weighing On Families
Benzinga
0:38
Amazon Web Services Invests $500 Million In Small Modular Nuclear Reactor To Power AI
Benzinga
0:38
Wells Fargo CEO Says US Consumer 'Extremely Resilient,' Sees Consumer Spending Rising Steadily
Benzinga
0:36
U.S. Crude Oil Prices Slip Below $71 on Middle East Tensions Easing
Benzinga
3:18
SHOCKING: Khalistani Leader Pannun Exposes SFJ’s Links to Trudeau’s Office in CBC Interview| Watch
Oneindia
0:30
Macy's Lowers Yearly Sales Forecast Amid Cautious Consumer Spending and Mixed Q2 Results
Benzinga
0:32
DoorDash Exceeds Revenue Expectations in Q2 Performance, Sees Surge in Total Orders
Benzinga
0:33
Pfizer's Q2 Revenue and Earnings Beat Expectations, as Sales of Pfizer's COVID Antiviral Pill Surpass Estimates
Benzinga
3:30
Watch| India's Supreme Court Unveils New Statue of Justice: Open Eyes and Constitution in Hand
Oneindia
3:25
The Kutch Story |Emami Agrotech Bleeds | Toxic Fumes Kill 5 Workers | WATCH
Oneindia
0:42
Pfizer's Share Price Falls After Disappointing Revenue Forecast
Benzinga
0:45
Salesforce Beats Earnings and Revenue Expectations
Benzinga
0:35
Novo Nordisk Raises Sales Growth Outlook Despite Profit Miss. CEO Predicts 'Attractive Growth' Amidst Competition and Regulation Shifts.
Benzinga
0:20
Pfizer Q2 Earnings
Benzinga
0:36
Peloton Sees First Revenue Growth Since 2021, But Its End-of-Year Forecast Remains Mixed
Benzinga
0:37
Target Raises Profit Guidance After Q2 Growth, Credits New Merchandise and Loyalty Programs
Benzinga
0:32
Best Buy's Q1 Earnings Disappoint on Revenue Miss Amid Soft Demand for Consumer Electronics
Benzinga
0:36
Home Depot Beats Q1 Earnings Expectations, but Revenue Falls Short as Customers Delay Renovation Projects
Benzinga
0:43
Procter & Gamble Beats Q1 Earnings Estimates
Benzinga
1:05
Procter & Gamble Surpasses Earnings Expectations
Benzinga
0:35
P&G Beats Earnings Expectations, But Revenue Falls Short as Consumers Struggle with Price Hikes
Benzinga